In the GBM dataset of the TCIA web platform (https://tcia.at/home), patients in the high-CP expression group exhibited significant immune escape in CTLA-4 and PD-1 positive GBM tissues compared to the low-CP expression group after anti-PD-1 and CTLA-4 treatments (Figure 8D). Here, CTLA4 is linked to glioblastoma.